Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 19/4/2018
SIETES contiene 92257 citas

 1 a 20 de 206 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol 2017;84:1. [Ref.ID 102184]
2. Cita con resumen
Wadström H, Frisell T, Askling J, for the Anti-Rheumatic Therapy in Sweden (ARTIS) Study Group. Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice. A nationwide cohort study from Sweden. JAMA Intern Med 2017;177:1605-12. [Ref.ID 102143]
3. Cita con resumen
Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R. Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease. JAMA 2017;318:1679-86. [Ref.ID 102138]
4.Tiene citas relacionadas Cita con resumen
Ropper AH. RetroSternal - Looking back at thymectomy for myasthenia gravis. N Engl J Med 2016;375:576-7. [Ref.ID 100576]
5.Tiene citas relacionadas Cita con resumen
Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo H-C, Marx A, Ströbel P, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chaik CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Días-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, García Ramos GS, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Newsom-Davis J, Cutter GR, for the MGTX Study Group. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 2016;375:511-22. [Ref.ID 100575]
6. Cita con resumen
Anónimo. Allopurinol + azathioprine: aplasies médullaires. Prescrire 2015;35:672. [Ref.ID 99720]
7. Cita con resumen
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]
8. Cita con resumen
Bewtra M, Newcomb CW, Wu Q, Chen L, Xie F, Roy JA, Aarons CB, Osterman MT, Forde KA, Curtis JR, Lewis JD. Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study. Ann Intern Med 2015;163:262-70. [Ref.ID 99499]
9. Cita con resumen
Anónimo. Consolidations de fracture retardées par des médicaments. Prescrire 2015;35:507-12. [Ref.ID 99440]
10.Tiene citas relacionadas Cita con resumen
De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Gibson PR, Sparrow M, Leong RW, Florin TH, Gearry RB, Radford-Smith G, Macrae FA, Debinski H, Selby W, Kronborg I, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV. Crohn's disease management after intestinal resection: a randomised trial. Lancet 2015;385:1406-17. [Ref.ID 99034]
11.Tiene citas relacionadas
Ananthakrishnan AN. Surgery for Crohn's disease: look harder, act faster. Lancet 2015;385:1370-1. [Ref.ID 99031]
12. Cita con resumen
Anónimo. Rituximab et polyangéites graves. Prescrire 2015;35:96-7. [Ref.ID 98912]
13. Cita con resumen
Anónimo. Drugs for rheumatoid arthritis. Med Lett Drugs Ther 2014;56:127-32. [Ref.ID 98445]
14.Tiene citas relacionadas Cita con resumen
Fox C, Hull R. Many drugs used for rheumatic disease cause neutropenia. BMJ 2014;349:g6450. [Ref.ID 98357]
15. Cita con resumen
Anónimo. Drugs for inflammatory bowel disease. Med Lett Drugs Ther 2014;56:59-66. [Ref.ID 98172]
16. Cita con resumen
Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]
17. Cita con resumen
Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144:1419-25. [Ref.ID 95639]
Cheifetz AS. Management of active Crohn disease. JAMA 2013;309:2150-8. [Ref.ID 95460]
19. Cita con resumen
Anónimo. Infliximab et rectocolite hémorragique des enfants. Prescrire 2013;33:99-100. [Ref.ID 94875]
20. Cita con resumen
Anónimo. Adalimumab et rectocolite hémorragique. Prescrire 2012;32:892. [Ref.ID 94193]
Seleccionar todas
 1 a 20 de 206 siguiente >>